136 result(s) have been found!
| Accession | Name | Sequence | Source/Organism | Mechanism | Assay Type | Cell Line | Cancer Type | Activity |
|---|---|---|---|---|---|---|---|---|
| dbacp01239 | Aurein 1.2 | GLFDIIKKIAESF | Southern bell frog Green and Golden Bell Frog, Australia | Cell membrane penetration | Not specified | Not specified | Not specified | LC50 : 10⁻⁵ to 10⁻⁴ M |
| dbacp01240 | Aurein 1.2 | GLFDIIKKIAESF | Southern Bell Frog | Cell membrane penetration | Not specified | Not specified | Not specified | LC50 : 10⁻⁵ to 10⁻⁴ M |
| dbacp01241 | Aurein 2.1 | GLLDIVKKVVGAFGSL | Southern bell frog, Australia | Cell membrane penetration | Not specified | Not found | Not found | Not found |
| dbacp01242 | Aurein 2.1 | GLLDIVKKVVGAFGSL | Southern bell frog, Australia | Cell membrane penetration | Not specified | Not specified | Not specified | LC50 : 10⁻⁵ to 10⁻⁴ M |
| dbacp01244 | Aurein 2.2 | GLFDIVKKVVGALGSL | Southern bell frog, Australia | Cell membrane penetration | Not specified | Not specified | Not specified | LC50 : 10⁻⁵ to 10⁻⁴ M |
| dbacp01246 | Aurein 2.3 | GLFDIVKKVVGAIGSL | Southern bell frog, Australia | Cell membrane penetration | Not specified | Not specified | Not specified | LC50 : 10⁻⁵ to 10⁻⁴ M |
| dbacp01248 | Aurein 2.4 | GLFDIVKKVVGTLAGL | Southern bell frog, Australia | Cell membrane penetration | Not specified | Not specified | Not specified | LC50 : 10⁻⁵ to 10⁻⁴ M |
| dbacp01249 | Aurein 2.5 | GLFDIVKKVVGAFGSL | Southern bell frog, Australia | Cell membrane penetration | Not specified | Not specified | Not specified | LC50 : 10⁻⁵ to 10⁻⁴ M |
| dbacp01250 | Aurein 2.6 | GLFDIAKKVIGVIGSL | Southern bell frog, Australia | Cell membrane penetration | Not specified | Not specified | Not specified | LC50 : 10⁻⁵ to 10⁻⁴ M |
| dbacp01251 | Aurein 3.1 | GLFDIVKKIAGHIAGSI | Southern bell frog, Australia | Cell membrane disruption | Not specified | Breast tumor cell line | Breast cancer | LC50 : 10-100 µM |
| dbacp01252 | Aurein 3.1 | GLFDIVKKIAGHIAGSI | Southern bell frog, Australia | Cell membrane disruption | Not specified | Leukemia tumor cell line | Leukemia cancer | LC50 : 10 µM |
| dbacp01253 | Aurein 3.1 | GLFDIVKKIAGHIAGSI | Southern bell frog, Australia | Cell membrane disruption | Not specified | Lung tumor cell line | Lung cancer | LC50 : 10 µM |
| dbacp01254 | Aurein 3.1 | GLFDIVKKIAGHIAGSI | Southern bell frog, Australia | Cell membrane disruption | Not specified | Colon tumor cell line | Colon cancer | LC50 : 10 µM |
| dbacp01255 | Aurein 3.1 | GLFDIVKKIAGHIAGSI | Southern bell frog, Australia | Cell membrane disruption | Not specified | Brain tumor cell line | Brain tumor | LC50 : 10-100 µM |
| dbacp01256 | Aurein 3.1 | GLFDIVKKIAGHIAGSI | Southern bell frog, Australia | Cell membrane disruption | Not specified | Skin tumor cell line | Skin cancer | LC50 : 10-100 µM |
| dbacp01257 | Aurein 3.1 | GLFDIVKKIAGHIAGSI | Southern bell frog, Australia | Cell membrane disruption | Not specified | Ovary tumor cell line | Ovarian cancer | LC50 : 10-100 µM |
| dbacp01258 | Aurein 3.1 | GLFDIVKKIAGHIAGSI | Southern bell frog, Australia | Cell membrane disruption | Not specified | Renal tumor cell line | Renal cancer | LC50 : 10-100 µM |
| dbacp01259 | Aurein 3.1 | GLFDIVKKIAGHIAGSI | Southern bell frog, Australia | Cell membrane disruption | Not specified | Prostate tumor cell line | Prostate cancer | LC50 : 10 µM |
| dbacp01260 | Aurein 3.1 | GLFDIVKKIAGHIAGSI | Southern bell frog, Australia | Cell membrane disruption | Not specified | Breast tumor cell line | Breast cancer | LC50 : 10-100 µM |
| dbacp01261 | Aurein 3.1 | GLFDIVKKIAGHIAGSI | Southern bell frog, Australia | Cell membrane disruption | Not specified | Leukemia tumor cell line | Leukemia cancer | LC50 : 10 µM |
| dbacp01262 | Aurein 3.1 | GLFDIVKKIAGHIAGSI | Southern bell frog, Australia | Cell membrane disruption | Not specified | Lung tumor cell line | Lung cancer | LC50 : 10 µM |
| dbacp01263 | Aurein 3.1 | GLFDIVKKIAGHIAGSI | Southern bell frog, Australia | Cell membrane disruption | Not specified | Colon tumor cell line | Colon cancer | LC50 : 10 µM |
| dbacp01264 | Aurein 3.1 | GLFDIVKKIAGHIAGSI | Southern bell frog, Australia | Cell membrane disruption | Not specified | Brain tumor cell line | Brain tumor | LC50 : 10-100 µM |
| dbacp01265 | Aurein 3.1 | GLFDIVKKIAGHIAGSI | Southern bell frog, Australia | Cell membrane disruption | Not specified | Skin tumor cell line | Skin cancer | LC50 : 10-100 µM |
| dbacp01266 | Aurein 3.1 | GLFDIVKKIAGHIAGSI | Southern bell frog, Australia | Cell membrane disruption | Not specified | Ovary tumor cell line | Ovarian cancer | LC50 : 10-100 µM |
| dbacp01267 | Aurein 3.1 | GLFDIVKKIAGHIAGSI | Southern bell frog, Australia | Cell membrane disruption | Not specified | Renal tumor cell line | Renal cancer | LC50 : 10-100 µM |
| dbacp01268 | Aurein 3.1 | GLFDIVKKIAGHIAGSI | Southern bell frog, Australia | Cell membrane disruption | Not specified | Prostate tumor cell line | Prostate cancer | LC50 : 10 µM |
| dbacp01269 | Aurein 3.1 | GLFDIVKKIAGHIAGSI | Southern bell frog, Australia | Cell membrane disruption | Not specified | Not specified | Not specified | LC50 : 10⁻⁵ to 10⁻⁴ M |
| dbacp01270 | Aurein 3.2 | GLFDIVKKIAGHIASSI | Southern bell frog, Australia | Cell membrane disruption | Not specified | Breast tumor cell line | Breast cancer | LC50 : 10 µM |
| dbacp01271 | Aurein 3.2 | GLFDIVKKIAGHIASSI | Southern bell frog, Australia | Cell membrane disruption | Not specified | Leukemia tumor cell line | Leukemia cancer | LC50 : 10 µM |
| dbacp01272 | Aurein 3.2 | GLFDIVKKIAGHIASSI | Southern bell frog, Australia | Cell membrane disruption | Not specified | Lung tumor cell line | Lung cancer | LC50 : 10 µM |
| dbacp01273 | Aurein 3.2 | GLFDIVKKIAGHIASSI | Southern bell frog, Australia | Cell membrane disruption | Not specified | Colon tumor cell line | Colon cancer | LC50 : 10-100 µM |
| dbacp01274 | Aurein 3.2 | GLFDIVKKIAGHIASSI | Southern bell frog, Australia | Cell membrane disruption | Not specified | Brain tumor cell line | Brain tumor | LC50 : 10 µM |
| dbacp01275 | Aurein 3.2 | GLFDIVKKIAGHIASSI | Southern bell frog, Australia | Cell membrane disruption | Not specified | Skin tumor cell line | Skin cancer | LC50 : 10 µM |
| dbacp01276 | Aurein 3.2 | GLFDIVKKIAGHIASSI | Southern bell frog, Australia | Cell membrane disruption | Not specified | Ovary tumor cell line | Ovarian cancer | LC50 : 10 µM |
| dbacp01277 | Aurein 3.2 | GLFDIVKKIAGHIASSI | Southern bell frog, Australia | Cell membrane disruption | Not specified | Renal tumor cell line | Renal cancer | LC50 : 10 µM |
| dbacp01278 | Aurein 3.2 | GLFDIVKKIAGHIASSI | Southern bell frog, Australia | Cell membrane disruption | Not specified | Prostate tumor cell line | Prostate cancer | LC50 : 10 µM |
| dbacp01279 | Aurein 3.2 | GLFDIVKKIAGHIASSI | Southern bell frog, Australia | Cell membrane disruption | Not specified | Not specified | Not specified | LC50 : 10⁻⁵ to 10⁻⁴ M |
| dbacp01280 | Aurein 3.3 | GLFDIVKKIAGHIVSSI | Southern bell frog, Australia | Cell membrane disruption | Not specified | Breast tumor cell line | Breast cancer | LC50 : 10 µM |
| dbacp01281 | Aurein 3.3 | GLFDIVKKIAGHIVSSI | Southern bell frog, Australia | Cell membrane disruption | Not specified | Leukemia tumor cell line | Leukemia cancer | LC50 : 10-100 µM |
| dbacp01282 | Aurein 3.3 | GLFDIVKKIAGHIVSSI | Southern bell frog, Australia | Cell membrane disruption | Not specified | Lung tumor cell line | Lung cancer | LC50 : 10 µM |
| dbacp01283 | Aurein 3.3 | GLFDIVKKIAGHIVSSI | Southern bell frog, Australia | Cell membrane disruption | Not specified | Colon tumor cell line | Colon cancer | LC50 : 10 µM |
| dbacp01284 | Aurein 3.3 | GLFDIVKKIAGHIVSSI | Southern bell frog, Australia | Cell membrane disruption | Not specified | Brain tumor cell line | Brain tumor | LC50 : 10 µM |
| dbacp01285 | Aurein 3.3 | GLFDIVKKIAGHIVSSI | Southern bell frog, Australia | Cell membrane disruption | Not specified | Skin tumor cell line | Skin cancer | LC50 : 10 µM |
| dbacp01286 | Aurein 3.3 | GLFDIVKKIAGHIVSSI | Southern bell frog, Australia | Cell membrane disruption | Not specified | Ovary tumor cell line | Ovarian cancer | LC50 : 10 µM |
| dbacp01287 | Aurein 3.3 | GLFDIVKKIAGHIVSSI | Southern bell frog, Australia | Cell membrane disruption | Not specified | Renal tumor cell line | Renal cancer | LC50 : 10 µM |
| dbacp01288 | Aurein 3.3 | GLFDIVKKIAGHIVSSI | Southern bell frog, Australia | Cell membrane disruption | Not specified | Prostate tumor cell line | Prostate cancer | LC50 : 10 µM |
| dbacp01289 | Aurein-1.1 | GLFDIIKKIAESI | Southern bell frog | Cell membrane disruption | Not specified | Not specified | Not specified | LC50 : 10⁻⁵ to 10⁻⁴ M |
| dbacp01290 | Aurein-1.2 | GLFDIIKKIAESF | Southern bell frog | Cell membrane disruption | Not specified | Not specified | Not specified | LC50 : 10⁻⁵ to 10⁻⁴ M |
| dbacp01291 | Aurein-1.2 | GLFDIIKKIAESF | Southern bell frog | Not specified | Not specified | Not found | Not found | Not found |
| dbacp01292 | Aurein-1.3 | GLFDIIKKIAESF | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | MOLT-4 | Leukemia | IC50 : 4-5 μM |
| dbacp01293 | Aurein-1.3 | GLFDIIKKIAESF | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | HOP-62 | Lung cancer | IC50 : 5 μM |
| dbacp01294 | Aurein-1.3 | GLFDIIKKIAESF | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | HCT-15 | Colon cancer | IC50 : 4-5 μM |
| dbacp01295 | Aurein-1.3 | GLFDIIKKIAESF | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | SF-539 | CNS cancer | IC50 : 5 μM |
| dbacp01296 | Aurein-1.3 | GLFDIIKKIAESF | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | MDA-MB-435 | Melanoma | IC50 : 5 μM |
| dbacp01297 | Aurein-1.3 | GLFDIIKKIAESF | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | OVCAR-4 | Ovarian cancer | IC50 : 5 μM |
| dbacp01298 | Aurein-1.3 | GLFDIIKKIAESF | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | CAKI-1 | Renal cancer | IC50 : 5 μM |
| dbacp01299 | Aurein-1.3 | GLFDIIKKIAESF | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | Not found | Prostate cancer | IC50 : 5 μM |
| dbacp01300 | Aurein-1.3 | GLFDIIKKIAESF | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | MDA-MB-468 | Breast cancer | IC50 : 5 μM |
| dbacp01301 | Aurein-2.1 | GLLDIVKKVVGAFGSL | Green; also golden bell frog; also southern bell frog | Not specified | Not specified | Not found | Not found | Not found |
| dbacp01302 | Aurein-2.1 [Cleaved into: Aurein-2.1.1] | GLLDIVKKVVGAFGSL | Southern bell frog | Cell membrane disintegration | Not specified | Not specified | Not specified | LC50 : 10⁻⁵ to 10⁻⁴ M |
| dbacp01344 | Aurein-2.5 | GLFDIVKKVVGAFGSL | Southern bell frog; also golden bell frog | Not specified | Not specified | Not found | Not found | Not found |
| dbacp01345 | Aurein-2.6 | GLFDIAKKVIGVIGSL | Southern bell frog | Membrane disruption | Not specified | Not specified | Not specified | LC50 : 10-5 - 10-4 M |
| dbacp01346 | Aurein-2.6 | GLFDIAKKVIGVIGSL | Southern bell frog | Not specified | Not specified | Not found | Not found | Not found |
| dbacp01347 | Aurein-2.7 | GLFDIAKKVIGVIGSL | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | RPMI-8226 | Leukemia | IC50 : 4-5 μM |
| dbacp01348 | Aurein-2.7 | GLFDIAKKVIGVIGSL | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | EKVX | Lung cancer | IC50 : 5 μM |
| dbacp01349 | Aurein-2.7 | GLFDIAKKVIGVIGSL | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | HT29 | Colon cancer | IC50 : 4-5 μM |
| dbacp01350 | Aurein-2.7 | GLFDIAKKVIGVIGSL | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | SF-295 | CNS cancer | IC50 : 5 μM |
| dbacp01351 | Aurein-2.7 | GLFDIAKKVIGVIGSL | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | SK-MEL-2 | Melanoma | IC50 : 5 μM |
| dbacp01352 | Aurein-2.7 | GLFDIAKKVIGVIGSL | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | OVCAR-3 | Ovarian cancer | IC50 : 5 μM |
| dbacp01353 | Aurein-2.7 | GLFDIAKKVIGVIGSL | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | RXF 393 | Renal cancer | IC50 : 5 μM |
| dbacp01354 | Aurein-2.7 | GLFDIAKKVIGVIGSL | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | DU-145 | Prostate cancer | IC50 : 5 μM |
| dbacp01355 | Aurein-2.7 | GLFDIAKKVIGVIGSL | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | MDA-MB-231/ATCC | Breast cancer | IC50 : 5 μM |
| dbacp01356 | Aurein-2.7 | GLFDIVKKIAGHIVSSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | SR | Leukemia | IC50 : 4-5 μM |
| dbacp01357 | Aurein-3.1 | GLFDIVKKIAGHIAGSI | Southern bell frog; also golden bell frog | Not specified | Not specified | Not found | Not found | Not found |
| dbacp01358 | Aurein-3.1 [Cleaved into: Aurein-3.1.1; Aurein-3.1.2] | GLFDIVKKIAGHIAGSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | CCRF-CEM | Leukemia | IC50 : 4-5 μM |
| dbacp01359 | Aurein-3.1 [Cleaved into: Aurein-3.1.1; Aurein-3.1.2] | GLFDIVKKIAGHIAGSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | NCI-H23 | Lung cancer | IC50 : 5 μM |
| dbacp01360 | Aurein-3.1 [Cleaved into: Aurein-3.1.1; Aurein-3.1.2] | GLFDIVKKIAGHIAGSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | COLO 205 | Colon cancer | IC50 : 4-5 μM |
| dbacp01361 | Aurein-3.1 [Cleaved into: Aurein-3.1.1; Aurein-3.1.2] | GLFDIVKKIAGHIAGSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | U251 | CNS cancer | IC50 : 5 μM |
| dbacp01362 | Aurein-3.1 [Cleaved into: Aurein-3.1.1; Aurein-3.1.2] | GLFDIVKKIAGHIAGSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | LOX IMVI | Melanoma | IC50 : 5 μM |
| dbacp01363 | Aurein-3.1 [Cleaved into: Aurein-3.1.1; Aurein-3.1.2] | GLFDIVKKIAGHIAGSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | NCI/ADR-RES | Ovarian cancer | IC50 : 5 μM |
| dbacp01364 | Aurein-3.1 [Cleaved into: Aurein-3.1.1; Aurein-3.1.2] | GLFDIVKKIAGHIAGSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | 786-0 | Renal cancer | IC50 : 5 μM |
| dbacp01365 | Aurein-3.1 [Cleaved into: Aurein-3.1.1; Aurein-3.1.2] | GLFDIVKKIAGHIAGSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | Not found | Prostate cancer | IC50 : 5 μM |
| dbacp01366 | Aurein-3.1 [Cleaved into: Aurein-3.1.1; Aurein-3.1.2] | GLFDIVKKIAGHIAGSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | BT-549 | Breast cancer | IC50 : 5 μM |
| dbacp01368 | Aurein-3.1 [Cleaved into: Aurein-3.1.1; Aurein-3.1.2] | GLFDIVKKIAGHIAGSI | Southern bell frog | Cell membrane disintegration | Not specified | Not specified | Not specified | LC50 : 10⁻⁵ - 10⁻⁴ M |
| dbacp01371 | Aurein-3.2 | GLFDIVKKIAGHIASSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | HL-60(TB) | Leukemia | IC50 : 4-5 μM |
| dbacp01372 | Aurein-3.2 | GLFDIVKKIAGHIASSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | NCI-H226 | Lung cancer | IC50 : 5 μM |
| dbacp01373 | Aurein-3.2 | GLFDIVKKIAGHIASSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | HCC-2998 | Colon cancer | IC50 : 4-5 μM |
| dbacp01374 | Aurein-3.2 | GLFDIVKKIAGHIASSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | SNB-75 | CNS cancer | IC50 : 5 μM |
| dbacp01375 | Aurein-3.2 | GLFDIVKKIAGHIASSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | MALME-3M | Melanoma | IC50 : 5 μM |
| dbacp01376 | Aurein-3.2 | GLFDIVKKIAGHIASSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | OVCAR-8 | Ovarian cancer | IC50 : 5 μM |
| dbacp01377 | Aurein-3.2 | GLFDIVKKIAGHIASSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | A498 | Renal cancer | IC50 : 5 μM |
| dbacp01378 | Aurein-3.2 | GLFDIVKKIAGHIASSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | Not found | Prostate cancer | IC50 : 5 μM |
| dbacp01379 | Aurein-3.2 | GLFDIVKKIAGHIASSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | MDA-N | Breast cancer | IC50 : 5 μM |
| dbacp01380 | Aurein-3.2 | GLFDIVKKIAGHIASSI | Southern bell frog | Cell membrane disintegration | Not specified | Not specified | Not specified | LC50 : 10⁻⁵ - 10⁻⁴ M |
| dbacp01384 | Aurein-3.3 [Cleaved into: Aurein-3.3.1] | GLFDIVKKIAGHIVSSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | A549/ATCC | Lung cancer | IC50 : 5 μM |
| dbacp01385 | Aurein-3.3 [Cleaved into: Aurein-3.3.1] | GLFDIVKKIAGHIVSSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | KM12 | Colon cancer | IC50 : 4 - 5 μM |
| dbacp01386 | Aurein-3.3 [Cleaved into: Aurein-3.3.1] | GLFDIVKKIAGHIVSSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | SF-268 | CNS cancer | IC50 : 5 μM |
| dbacp01387 | Aurein-3.3 [Cleaved into: Aurein-3.3.1] | GLFDIVKKIAGHIVSSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | SK-MEL-28 | Melanoma | IC50 : 5 μM |
| dbacp01388 | Aurein-3.3 [Cleaved into: Aurein-3.3.1] | GLFDIVKKIAGHIVSSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | IGR-OV1 | Ovarian cancer | IC50 : 5 μM |
| dbacp01389 | Aurein-3.3 [Cleaved into: Aurein-3.3.1] | GLFDIVKKIAGHIVSSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | SN12C | Renal cancer | IC50 : 5 μM |
| dbacp01390 | Aurein-3.3 [Cleaved into: Aurein-3.3.1] | GLFDIVKKIAGHIVSSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | PC-3 | Prostate cancer | IC50 : 5 μM |
| dbacp01391 | Aurein-3.3 [Cleaved into: Aurein-3.3.1] | GLFDIVKKIAGHIVSSI | Southern bell frog | Cell membrane disintegration | One-dose and five-dose assay | MCF7 | Breast cancer | IC50 : 5 μM |
| dbacp01392 | Aurein-3.3 [Cleaved into: Aurein-3.3.1] | GLFDIVKKIAGHIVSSI | Southern bell frog | Cell membrane disintegration | Not specified | Not specified | Not specified | LC50 : 10⁻⁵ - 10⁻⁴ M |
| dbacp01393 | Aurein-3.3.1 | FDIVKKIAGHIVSSI | Southern bell frog | Cell membrane disintegration | Not specified | Not found | Not found | Not found |
| dbacp01395 | Aurein-4.2 | GLLQTIKEKLKEFAGGVVTGVQS | Southern bell frog | Cell membrane disintegration | Not specified | Not specified | Not specified | LC50 : 10⁻⁵ - 10⁻⁴ M |
| dbacp01398 | Aurein-4.4 | GLLQTIKEKLKELATGLVIGVQS | Southern bell frog | Cell membrane disintegration | Not specified | Not specified | Not specified | LC50 : 10⁻⁵ - 10⁻⁴ M |
| dbacp01400 | Aurein-5.1 | GLLDIVTGLLGNLIVDVLKPKTPAS | Southern bell frog | Cell membrane disintegration | Not specified | Not specified | Not specified | LC50 : 10⁻⁵ - 10⁻⁴ M |
| dbacp01402 | Aurein-5.2 | GLMSSIGKALGGLIVDVLKPKTPAS | Southern bell frog | Cell membrane disintegration | Not specified | Not specified | Not specified | LC50 : 10⁻⁵ - 10⁻⁴ M |
| dbacp01405 | Aurein1.2 | GLFDIIKKIAESF | Southern bell frog | Cell membrane disruption | Not specified | Breast tumor cell line | Breast cancer | LC50 : 10 µM |
| dbacp01406 | Aurein1.2 | GLFDIIKKIAESF | Southern bell frog | Cell membrane disruption | Not specified | Leukemia tumor cell line | Leukemia cancer | LC50 : 10-100 µM |
| dbacp01407 | Aurein1.2 | GLFDIIKKIAESF | Southern bell frog | Cell membrane disruption | Not specified | Lung tumor cell line | Lung cancer | LC50 : 10 µM |
| dbacp01408 | Aurein1.2 | GLFDIIKKIAESF | Southern bell frog | Cell membrane disruption | Not specified | Colon tumor cell line | Colon cancer | LC50 : 10 µM |
| dbacp01409 | Aurein1.2 | GLFDIIKKIAESF | Southern bell frog | Cell membrane disruption | Not specified | Brain tumor cell line | Brain tumor | LC50 : 10 µM |
| dbacp01410 | Aurein1.2 | GLFDIIKKIAESF | Southern bell frog | Cell membrane disruption | Not specified | Skin tumor cell line | Skin cancer | LC50 : 10 µM |
| dbacp01411 | Aurein1.2 | GLFDIIKKIAESF | Southern bell frog | Cell membrane disruption | Not specified | Ovary tumor cell line | Ovarian cancer | LC50 : 10 µM |
| dbacp01412 | Aurein1.2 | GLFDIIKKIAESF | Southern bell frog | Cell membrane disruption | Not specified | Renal tumor cell line | Renal cancer | LC50 : 10 µM |
| dbacp01413 | Aurein1.2 | GLFDIIKKIAESF | Southern bell frog | Cell membrane disruption | Not specified | Prostate tumor cell line | Prostate cancer | LC50 : 10 µM |
| dbacp01414 | Aurein2.5 | GLFDIVKKVVGAFGSL | Southern bell frog | Cell membrane disruption | Not specified | Breast tumor cell line | Breast cancer | LC50 : 10 µM |
| dbacp01415 | Aurein2.5 | GLFDIVKKVVGAFGSL | Southern bell frog | Cell membrane disruption | Not specified | Leukemia tumor cell line | Leukemia cancer | LC50 : 10-100 µM |
| dbacp01416 | Aurein2.5 | GLFDIVKKVVGAFGSL | Southern bell frog | Cell membrane disruption | Not specified | Lung tumor cell line | Lung cancer | LC50 : 10 µM |
| dbacp01417 | Aurein2.5 | GLFDIVKKVVGAFGSL | Southern bell frog | Cell membrane disruption | Not specified | Colon tumor cell line | Colon cancer | LC50 : 10-100 µM |
| dbacp01418 | Aurein2.5 | GLFDIVKKVVGAFGSL | Southern bell frog | Cell membrane disruption | Not specified | Brain tumor cell line | Brain tumor | LC50 : 10 µM |
| dbacp01419 | Aurein2.5 | GLFDIVKKVVGAFGSL | Southern bell frog | Cell membrane disruption | Not specified | Skin tumor cell line | Skin cancer | LC50 : 10 µM |
| dbacp01420 | Aurein2.5 | GLFDIVKKVVGAFGSL | Southern bell frog | Cell membrane disruption | Not specified | Ovary tumor cell line | Ovarian cancer | LC50 : 10 µM |
| dbacp01421 | Aurein2.5 | GLFDIVKKVVGAFGSL | Southern bell frog | Cell membrane disruption | Not specified | Renal tumor cell line | Renal cancer | LC50 : 10 µM |
| dbacp01422 | Aurein2.5 | GLFDIVKKVVGAFGSL | Southern bell frog | Cell membrane disruption | Not specified | Prostate tumor cell line | Prostate cancer | LC50 : 10 µM |
| dbacp01423 | Aurein2.6 | GLFDIAKKVIGVIGSL | Southern bell frog | Cell membrane disruption | Not specified | Breast tumor cell line | Breast cancer | LC50 : 10 µM |
| dbacp01424 | Aurein2.6 | GLFDIAKKVIGVIGSL | Southern bell frog | Cell membrane disruption | Not specified | Leukemia tumor cell line | Leukemia cancer | LC50 : 10-100 µM |
| dbacp01425 | Aurein2.6 | GLFDIAKKVIGVIGSL | Southern bell frog | Cell membrane disruption | Not specified | Lung tumor cell line | Lung cancer | LC50 : 10 µM |
| dbacp01426 | Aurein2.6 | GLFDIAKKVIGVIGSL | Southern bell frog | Cell membrane disruption | Not specified | Colon tumor cell line | Colon cancer | LC50 : 10-100 µM |
| dbacp01427 | Aurein2.6 | GLFDIAKKVIGVIGSL | Southern bell frog | Cell membrane disruption | Not specified | Brain tumor cell line | Brain tumor | LC50 : 10 µM |
| dbacp01428 | Aurein2.6 | GLFDIAKKVIGVIGSL | Southern bell frog | Cell membrane disruption | Not specified | Skin tumor cell line | Skin cancer | LC50 : 10 µM |
| dbacp01429 | Aurein2.6 | GLFDIAKKVIGVIGSL | Southern bell frog | Cell membrane disruption | Not specified | Ovary tumor cell line | Ovarian cancer | LC50 : 10 µM |
| dbacp01430 | Aurein2.6 | GLFDIAKKVIGVIGSL | Southern bell frog | Cell membrane disruption | Not specified | Renal tumor cell line | Renal cancer | LC50 : 10 µM |
| dbacp01431 | Aurein2.6 | GLFDIAKKVIGVIGSL | Southern bell frog | Cell membrane disruption | Not specified | Prostate tumor cell line | Prostate cancer | LC50 : 10 µM |